Review
doi: 10.3949/ccjm.86a.18024.
ACE inhibitors and ARBs: Managing potassium and renal function
Affiliations
- PMID: 31498767
- DOI: 10.3949/ccjm.86a.18024
Item in Clipboard
Review
ACE inhibitors and ARBs: Managing potassium and renal function
Cleve Clin J Med.
2019 Sep.
Abstract
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are used primarily to treat hypertension and are also useful for conditions such as heart failure and chronic kidney disease, independent of their effect on blood pressure. This article reviews the indications for ACE inhibitors and ARBs and offers advice for managing their adverse effects, particularly declining renal function and hyperkalemia.
Copyright © 2019 Cleveland Clinic.
Comment in
-
ACE inhibitor and ARB therapy: Practical recommendations.Cleve Clin J Med. 2019 Sep;86(9):608-611. doi: 10.3949/ccjm.86a.19016. Cleve Clin J Med. 2019. PMID: 31498762 No abstract available.
-
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?Cleve Clin J Med. 2020 Jan;87(1):9. doi: 10.3949/ccjm.87c.01001. Epub 2020 Jan 2. Cleve Clin J Med. 2020. PMID: 31990645 No abstract available.